Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 627

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1B
Chunk 627
---
 to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected
not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different
application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised
standards at the time the private companies adopt the new or revised standard. This may make the comparison of the Company’s
consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth
company that has opted out of using the extended transition period difficult or impossible because of the potential differences
in accounting standards used.

NOTE 2–SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 

Principles of Consolidation

The accompanying consolidated
financial statements include the accounts of OSR, Inc. and its wholly owned operating subsidiary, OSR Co., Ltd. There has been no intercompany
activity since inception.

Use of Estimates 

The preparation of
consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the consolidated
financial statements and the reported amounts of expenses during the reporting periods.

Making estimates requires management to
exercise significant judgment. It is at least reasonably possible that the estimate of the effects of a condition, situation or set
of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its
estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.

Cash and Cash Equivalents 

The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company had $66,135 and $15,419 in
cash held in its operating account as of December 31, 2024 and 2023, respectively. The Company had no cash equivalents
as of December 31, 2024 and 2023.

Fair Value of Financial Instruments 

The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates
the carrying amounts represented in the consolidated financial statements, primarily due to their short-term nature.

Investments